Literature DB >> 21896564

Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials.

Eugene Braunwald.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21896564     DOI: 10.1093/eurheartj/ehr310

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  13 in total

Review 1.  The evolution or revolution of statin therapy in primary prevention: where do we go from here?

Authors:  Patricia Rehfield; Colin Kopes-Kerr; Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

Review 2.  Anti-inflammatory therapies for cardiovascular disease.

Authors:  Paul M Ridker; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2014-05-26       Impact factor: 29.983

Review 3.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 4.  Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?

Authors:  Paul M Ridker
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

5.  Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?

Authors:  Paul M Ridker
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

6.  Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy.

Authors:  Aruna D Pradhan; Aaron W Aday; Lynda M Rose; Paul M Ridker
Journal:  Circulation       Date:  2018-05-01       Impact factor: 29.690

7.  Hyperlipidemia as an instigator of inflammation: inaugurating new approaches to vascular prevention.

Authors:  Paul M Ridker
Journal:  J Am Heart Assoc       Date:  2012-02-20       Impact factor: 5.501

8.  Antihyperlipidemic, anti-inflammatory, analgesic, and antipyretic activities of "dimethyl dimethoxy biphenyl dicarboxylate" in male Wistar rats.

Authors:  Heba M I Abdallah; Gihan F Asaad; Mahmoud S Arbid; Yousra A Nomier
Journal:  J Adv Pharm Technol Res       Date:  2022-04-07

9.  Associations between pentraxin 3 and severity of coronary artery disease.

Authors:  Hua Liu; Shaofeng Guan; Weiyi Fang; Fang Yuan; Min Zhang; Xinkai Qu
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

10.  Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease.

Authors:  Syed Shahid Habib; Abeer A Al Masri
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.